Reprieve Cardiovascular
Reprieve Cardiovascular is a startup headquartered in Milford, United States, founded in 2020. It has raised at least $47.9m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Reprieve Cardiovascular has raised at least $47.9m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Reprieve Cardiovascular sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Milford
Related
- Innovation profile of Milford
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Reprieve Cardiovascular do?
Reprieve Cardiovascular is classed in healthcare in its filings with the US Securities and Exchange Commission.
How much has Reprieve Cardiovascular raised?
At least $47.9m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Reprieve Cardiovascular based?
Reprieve Cardiovascular is headquartered in Milford, United States.
When was Reprieve Cardiovascular founded?
Reprieve Cardiovascular was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.